Clinical Trial Update: Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating GLP-1 receptor agonists in combination with total neoadjuvant therapy for rectal cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Rectal Cancer

Drugs mentioned

• GLP-1 receptor agonists

Snippet

Sponsor: St. James's Hospital, Ireland | Conditions: Rectal Cancer Patients, Obesity &Amp; Overweight | Phase 2 | Status: NOT_YET_RECRUITING